American investor and philanthropist Larry Robbins was born in 1969. He oversees Glenview Capital’s portfolio and serves as its CEO. Larry Robbins’ current net worth is estimated by Forbes to be about $2 billion. Robbins favors owning stocks without using stop losses for extended periods. He favors well-established businesses that provide consistent revenues. Robbins was one of the first investors to start making significant bets on the Affordable Care Act and the healthcare industry. Larry Robbins started Glenview Capital in 2000. It holds investments in a number of industries, including healthcare, manufacturing, and consumer services. Compared to the average hedge fund return of just 8%, the fund’s 2019 gains of 29.91% were astounding.
Insider Monkey highlights the 10 healthcare stocks to buy now according to billionaire Larry Robbins. Glenview Capital has a 1.24 percent concentration in the entire holdings of the company and held 1.38 million shares of Boston Scientific Corporation for $61.3 million. In Q1 2022, the company was included in 55 hedge fund portfolios with total interests worth $4.67 billion. A US-based operator of healthcare facilities is HCA Healthcare, Inc. In the US and the UK, the firm manages close to 190 hospitals and 2,000 care facilities. Glenview Capital owned shares of the company valued at $79.4 million as of the end of the first quarter of 2022. A $0.20 quarterly cash dividend will be distributed to shareholders of record as of September 1, 2022 by Universal Health Services, Inc. In the first quarter of 2022, First Eagle Investment Management held the largest share in the business. In the first quarter of 2022, Glenview Capital expanded its stake in the business by 73%. Glenview Capital’s holdings included 1.85 percent of Encompass Health Corporation. The company’s operations are centered on its three divisions: hospice, home health, and inpatient rehabilitation. Located in St. Louis, Missouri, Centene Corporation is a managed-care organization. The company declared its withdrawal from the pharmaceutical benefit management industry in May. For $2.8 billion, the business sold PANTHERx Rare and Magellan Rx. For more details, click 10 Healthcare Stocks To Buy Now According To Billionaire Larry Robbins.
